In this issue:
Pegcetacoplan vs. ravulizumab or eculizumab in complement inhibitor-naïve PNH
Intravenous vs. oral iron for deficiency prior to colorectal cancer surgery
Hydroxycarbamide for reducing stroke risk in paediatric sickle cell anaemia
Adding carfilzomib to RICE for relapsed/refractory DLBCL
Crizanlizumab in sickle cell disease
Pembrolizumab for disease relapse after allogeneic SCT
Immunosuppression ± eltrombopag in paediatric aplastic anaemia
Sutimlimab for chronic ITP
Australian experience with ibrutinib for relapsed/refractory MCL
Ibrutinib for relapsed/refractory Waldenström macroglobulinaemia
Please login below to download this issue (PDF)